CORFLOW THERAPEUTICS AG
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complication rates in these patients.
CORFLOW THERAPEUTICS AG
Industry:
Medical Medical Device
Founded:
2016-01-01
Address:
Baar, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.corflow-therapeutics.ch
Total Employee:
11+
Status:
Active
Contact:
+41 41 544 55 55
Email Addresses:
[email protected]
Total Funding:
16.7 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS ASP.NET IIS IIS 10
Similar Organizations
Sensome
Sensome offers micro-sensor technology to turn medical devices into connected healthcare devices.
Current Employees Featured
Founder
Investors List
415 CAPITAL
415 CAPITAL investment in Series A - CorFlow Therapeutics AG
InnoSuisse
InnoSuisse investment in Grant - CorFlow Therapeutics AG
Arshad Quadri
Arshad Quadri investment in Seed Round - CorFlow Therapeutics AG
Jean-Claude Laborde
Jean-Claude Laborde investment in Seed Round - CorFlow Therapeutics AG
Jacques R. Seguin
Jacques R. Seguin investment in Seed Round - CorFlow Therapeutics AG
Official Site Inspections
http://www.corflow-therapeutics.ch
Unable to get host informations!!!
More informations about "CorFlow Therapeutics AG"
Home - Corflow
News Press releases Our Office +41 41 399 18 00 CorFlow Therapeutics AG Neuhofstrasse 5A 6340 Baar, Switzerland [email protected] See details»
CorFlow Therapeutics - Crunchbase Company Profile
CorFlow Therapeutics is a medtech startup that develops proprietary … See details»
CorFlow Therapeutics AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CorFlow Therapeutics AG of Baar, ZUG. Get the latest business insights from Dun & Bradstreet. See details»
CorFlow Therapeutics AG - startup.ch
CorFlow Therapeutics AG Combined diagnostic and therapeutic medical device for improving microvascular obstructions after a heart attack Several arterial … See details»
CorFlow Therapeutics Company Profile - Office Locations ... - Craft
CorFlow Therapeutics has 5 employees at their 1 location. See insights on CorFlow Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more … See details»
CorFlow Therapeutics AG - VentureRadar
"CorFlow Therapeutics AG is focused on developing innovative medical devices to address microvascular obstruction (MVO) in heart attack patients. Their flagship product, the CorFlow … See details»
CorFlow Therapeutics AG, Baar | business-monitor.ch
Das Unternehmen CorFlow Therapeutics AG ist eine AG mit Sitz in Baar, im Kanton Zug, die im Jahr 2016 gegründet wurde. Seine Identifikationsnummer UID lautet CHE-320.873.257. See details»
CorFlow Therapeutics Announces FDA Approval of the
2 days ago Contact CorFlow Therapeutics AG Media and Scientific Contact [email protected] This news is a press release provided by CorFlow Therapeutics AG. See details»
Contact Us - Corflow
Contact us Office +41 41 399 18 00 send email [email protected] Our Office CorFlow Therapeutics AG Neuhofstrasse 5A 6340 Baar, Switzerland Please contact us for interest in … See details»
CorFlow Therapeutics AG Completes €44 Million Series …
Sep 10, 2024 Share this story BAAR, Switzerland– (BUSINESS WIRE)– CorFlow Therapeutics AG (CorFlow) announced today that it has raised €44 … See details»
CorFlow Therapeutics company information, funding & investors
Jul 1, 2016 CorFlow Therapeutics, the first combined diagnostic and therapeutic medical device for improving microvascular obstructions after a heart attack. Here you'll find information about … See details»
CorFlow Therapeutics Announces FDA Approval of the MOCA-II …
3 days ago CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug … See details»
CorFlow Therapeutics raises €44 million in Series B round
Dec 9, 2024 Medtech startup CorFlow Therapeutics AG has completed a €44 million in Series B funding round backed by a top-tier global syndicate of medical technology investors. The funds … See details»
Who we are - Corflow
Who we are Corflow Vision To be the leader in diagnostic and therapeutic solutions for restoring healthy microvascular blood flow anywhere in the human body where a critical need exists. … See details»
Team - Corflow
The CorFlow Team Senior Managment Team Paul G. Mead CEO 18 years at Medtronic, 14 years in the fields of vascular and interventional cardiology. Oliver Bludau COO 10+ yrs experience … See details»
Impressum - Corflow
CorFlow Therapeutics AG Neuhofstrasse 3d CH-6340 Baar, Switzerland Tel: (+41) 41 399 18 00E-Mail: [email protected] VAT:CHE 320.873.257 MWST See details»
News - Corflow
Mar 1, 2024 Press Releases BREAKING NEWS: Tuesday 6th May 2025 CorFlow Therapeutics appoints Chris O’Connell as Chairman of the Board of Directors We are absolutely thrilled to … See details»
CorFlow Therapeutics宣布MOCA-II IDE關鍵性試驗獲得FDA核准， …
2 days ago 關於CorFlow Therapeutics：公司總部位於瑞士巴爾，在義大利和美國設有子公司。 CorFlow由國際創投公司共同投資，最近一輪融資是2024年9月宣布的B輪融資。 See details»
CorFlow Therapeutics Announces FDA Approval of the MOCA-II …
3 days ago BAAR, Switzerland– (BUSINESS WIRE)– CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today … See details»
CorFlow Therapeutics AG Completes €44 Million Series B …
Oct 9, 2024 BAAR, Switzerland – CorFlow Therapeutics AG (CorFlow) announced today that it has raised €44 million in Series B funding, co-led by Broadview Ventures and Panakes … See details»